Paclitaxel-eluting stents in coronary artery disease
- 1 November 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 62 (21) , 2241-2251
- https://doi.org/10.2146/ajhp040621
Abstract
Purpose. Clinical information regarding paclitaxel-eluting coronary artery stents is reviewed.Keywords
This publication has 47 references indexed in Scilit:
- The Effects of Paclitaxel on the Three Phases of RestenosisInvestigative Radiology, 2004
- Management of Patients Undergoing Percutaneous Coronary RevascularizationAnnals of Internal Medicine, 2003
- Drug-eluting stents in vascular interventionThe Lancet, 2003
- ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and InterventionsJournal of the American College of Cardiology, 2001
- Arterial Remodeling After Coronary AngioplastyCirculation, 1996
- A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1994
- A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery DiseaseNew England Journal of Medicine, 1994
- Percutaneous transluminal coronary angioplasty: Report from the registry of the National Heart, Lung, and Blood InstituteThe American Journal of Cardiology, 1982
- Restoration of normal coronary hemodynamics and myocardial metabolism after percutaneous transluminal coronary angioplasty.Circulation, 1980
- Nonoperative Dilatation of Coronary-Artery StenosisNew England Journal of Medicine, 1979